312 related articles for article (PubMed ID: 17303109)
1. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
2. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
4. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
[TBL] [Abstract][Full Text] [Related]
6. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
[TBL] [Abstract][Full Text] [Related]
7. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
Carbajo-Pescador S; Martín-Renedo J; García-Palomo A; Tuñón MJ; Mauriz JL; González-Gallego J
J Pineal Res; 2009 Nov; 47(4):330-8. PubMed ID: 19817970
[TBL] [Abstract][Full Text] [Related]
8. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
Girgert R; Hanf V; Emons G; Gründker C
Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain.
Niles LP; Sathiyapalan A; Bahna S; Kang NH; Pan Y
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1343-50. PubMed ID: 22243807
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
12. Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells.
McMillan CR; Sharma R; Ottenhof T; Niles LP
Neurosci Lett; 2007 Jun; 419(3):202-6. PubMed ID: 17482356
[TBL] [Abstract][Full Text] [Related]
13. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line.
Watanabe M; Kobayashi Y; Takahashi N; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2008 Aug; 34(4):567-73. PubMed ID: 18937711
[TBL] [Abstract][Full Text] [Related]
14. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system.
Uz T; Arslan AD; Kurtuncu M; Imbesi M; Akhisaroglu M; Dwivedi Y; Pandey GN; Manev H
Brain Res Mol Brain Res; 2005 May; 136(1-2):45-53. PubMed ID: 15893586
[TBL] [Abstract][Full Text] [Related]
15. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
16. Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease.
Bahna SG; Sathiyapalan A; Foster JA; Niles LP
Neurosci Lett; 2014 Jul; 576():84-7. PubMed ID: 24909617
[TBL] [Abstract][Full Text] [Related]
17. 5-Azacytidine upregulates melatonin MT
Hartung EE; Mukhtar SZ; Shah SM; Niles LP
Mol Biol Rep; 2020 Jun; 47(6):4867-4873. PubMed ID: 32410138
[TBL] [Abstract][Full Text] [Related]
18. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
Hill SM; Blask DE
Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
[TBL] [Abstract][Full Text] [Related]
20. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.
Carbajo-Pescador S; García-Palomo A; Martín-Renedo J; Piva M; González-Gallego J; Mauriz JL
J Pineal Res; 2011 Nov; 51(4):463-71. PubMed ID: 21718361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
